Androgenetic Alopecia

September 2004 in “ Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) ”

V. del Mármol, C. Jouanique

androgenetic alopecia androgens hair follicle miniaturization topical minoxidil oral finasteride Rogaine Propecia

From the encyclopedia

An essential vasodilator with some anti-androgenic effects

Frontline, gold standard treatment for combatting androgenic alopecia

Studysummary This article reviews treatments for androgenic alopecia, discussing options like minoxidil for both genders and specific therapies for men and women, but it reports no new clinical results.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

View this study on hdl.handle.net →

Discuss this study in the Community →

Research cited in this study

9 / 9 results

research A Randomized, Placebo-Controlled Trial of 5% and 2% Topical Minoxidil Solutions in the Treatment of Female Pattern Hair Loss

219 citations , March 2004 in “Journal of The American Academy of Dermatology”

In this 48-week trial, 5% topical minoxidil was more effective than both 2% minoxidil and placebo in promoting hair growth in women with female pattern hair loss, with notable improvements in nonvellus hair count and hair growth assessments.

research Efficacy and Tolerability of Finasteride 1 mg in Men Aged 41 to 60 Years with Male Pattern Hair Loss

22 citations , July 2003 in “PubMed”

This study reported that finasteride 1 mg significantly improved hair growth in men aged 41 to 60 with predominantly vertex male pattern hair loss over 24 months compared to placebo.

research Use of Finasteride in the Treatment of Men With Androgenetic Alopecia

38 citations , June 2003 in “Journal of Investigative Dermatology Symposium Proceedings”

This review summarizes existing research on the use of finasteride for treating androgenetic alopecia in men, reporting its effectiveness at 1 mg/day and a strong safety profile, but presents no new findings.

research Androgenetic Alopecia in Men and Women

77 citations , March 2001 in “Clinics in Dermatology”

This article discusses treatment approaches for female pattern hair loss and concludes that available medical treatments are effective in reversing or stabilizing the condition in most cases of mild-to-moderate severity.

research Lack of Efficacy of Finasteride in Postmenopausal Women with Androgenetic Alopecia

239 citations , November 2000 in “Journal of The American Academy of Dermatology”

In this study, finasteride 1 mg/day for 12 months did not improve hair growth or slow hair thinning in postmenopausal women with androgenetic alopecia compared to placebo.

research The Effects of Finasteride on Scalp Skin and Serum Androgen Levels in Men with Androgenetic Alopecia

65 citations , October 1999 in “Journal of The American Academy of Dermatology”

In this study, finasteride doses as low as 0.2 mg per day significantly reduced both scalp skin and serum DHT levels in men with androgenetic alopecia.

research Finasteride in a 1-Mg Dose Is Safe and Effective

5 citations , August 1999 in “Archives of Dermatology”

research Improvement in Androgenetic Alopecia (Stage V) Using Topical Minoxidil in a Retinoid Vehicle and Oral Finasteride

23 citations , December 1995 in “Archives of Dermatology”

This case report discusses a 32-year-old man's treatment for advanced androgenetic alopecia using a combination of topical minoxidil and oral finasteride, but no clinical outcomes are detailed.

research Disorders of Hair Growth: Diagnosis and Treatment

26 citations , January 1994 in “McGraw-Hill eBooks”

This review discusses various aspects of hair biology and pathology, including hair growth control, hair loss causes, and scalp conditions, and reports no clinical results.